Retatrutide 10mg | Triple Agonist Research Peptide

Retatrutide 10mg is a next-generation research peptide known for its unique triple agonist activity, targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This multi-pathway mechanism has positioned it at the forefront of metabolic and endocrine research.

In laboratory environments, retatrutide is studied for its potential influence on energy balance, appetite signaling, and metabolic regulation. Unlike traditional single- or dual-pathway compounds, its triple receptor activity allows researchers to explore a broader range of physiological effects.

Researchers are particularly interested in retatrutide for its potential to:

• Support studies on appetite regulation and satiety signaling

• Influence body weight and fat metabolism research

• Enhance understanding of energy expenditure mechanisms

• Improve glucose metabolism and insulin sensitivity pathways

• Explore combined incretin and glucagon receptor activity

This compound has gained significant attention for its role in advancing research related to obesity, metabolic disorders, and whole-body energy regulation.

Product Specifications

• Compound: Retatrutide

• Quantity: 10mg per vial

• Purity: ≥99% (research-grade standard)

• Appearance: Lyophilized white powder

• Storage: Store in a cool, dry environment

• Stability: Maintain proper storage conditions before and after reconstitution

Important Notice

This product is intended strictly for research purposes only.